Skip to main content
LobbyMap

Apex Bio Capital

Defense & Aerospace · Lobbying Client

C
Influence Score
47/100
Moderate Influence
$1.9M
Total Lobby Spend
6
Policy Issues
1
Lobbyists
0
Revolving Door

Apex Bio Capital reported $1.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Defense, Aerospace, Budget/Appropriations. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Housing & Urban Development
Dept of Health & Human Services
White House
Federal Trade Commission
Federal Energy Regulatory Commission
National Science Foundation
Dept of Labor

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarK&L Gates LLP
AERTOU
1$73K
2020 Apr-JunAkin Gump LLP
BUD
1$101K
2020 Jul-SepSquire Patton Boggs LLP
AERBUDTOU
1$84K
2020 Oct-DecK&L Gates LLP
FIN
1$111K
2021 Jan-MarCovington & Burling LLP
DEFGOV
1$75K
2021 Apr-JunCovington & Burling LLP
GOVFINDEF+2
1$133K
2021 Jul-SepHolland & Knight LLP
AER
1$76K
2021 Oct-DecAkin Gump LLP
TOU
1$125K

Apex Bio Capital Lobbying FAQ

Apex Bio Capital has spent $1.9M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Apex Bio Capital lobbies on 6 policy issues, including Defense, Aerospace, Budget/Appropriations, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Apex Bio Capital has an Influence Score of 47/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Apex Bio Capital employs 1 registered lobbyists, of whom 0 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Apex Bio Capital has contacted 7 government entities as part of their lobbying activities, including Dept of Housing & Urban Development, Dept of Health & Human Services, White House.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.